Ascent Pharmaceuticals, Inc.
Ascent Pharmaceuticals, Inc. appears in FDA public data with 3 recalls, 0 510(k) clearances, 9 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0276-2022, Class II) was initiated on November 19, 2021.
Summary
- Total Recalls
- 3
- 510(k) Clearances
- 0
- Inspections
- 9
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0276-2022 | Class II | Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325 mg, 100-count bottle, Rx only, Manuf | November 19, 2021 |
| D-0097-2021 | Class II | Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/325mg 100-count bottles, Rx Only, Manufa | October 26, 2020 |
| D-0248-2018 | Class III | Oxycodone Hydrochloride Tablets, USP 15 mg, 100 count bottles, Rx only, Manufactured for Camber Phar | January 22, 2018 |